
    
      This study is a randomised, double-blinded, double-dummy, placebo-controlled study to
      demonstrate the efficacy of oral hydrochlorothiazide or spironolactone in combination with
      intravenous furosemide compared to intravenous furosemide in combination with placebo. Dosage
      of intravenous furosemide will be adjusted according to pre-defined protocol. The primary
      outcome is urine volume during 72 hours after randomisation.
    
  